Medullary thyroid cancer historical perspective: Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:
==Historical Perspective==
==Historical Perspective==
* In 1959, Hazard et al. described medullary (solid) thyroid carcinoma.<ref name="pmid17555398">{{cite journal  |vauthors=Dionigi G, Bianchi V, Rovera F, etal |title=Medullary thyroid carcinoma: surgical treatment advances |journal=Expert Rev Anticancer Ther |volume=7 |issue=6 |pages=877–85 |year=2007 |pmid=17555398 |doi=10.1586/14737140.7.6.877}}</ref>
* In 1959, Hazard et al. described medullary (solid) thyroid carcinoma.<ref name="pmid17555398">{{cite journal  |vauthors=Dionigi G, Bianchi V, Rovera F, etal |title=Medullary thyroid carcinoma: surgical treatment advances |journal=Expert Rev Anticancer Ther |volume=7 |issue=6 |pages=877–85 |year=2007 |pmid=17555398 |doi=10.1586/14737140.7.6.877}}</ref>
* In 1961, Sipple described a combination of a [[pheochromocytoma]], medullary thyroid carcinoma and [[parathyroid adenoma]].
* In 1961, Sipple described a combination of a [[pheochromocytoma]], medullary thyroid carcinoma, and [[parathyroid adenoma]].
* In 1966, Williams ''et al.'' described the combination of mucosal neuromas, [[pheochromocytoma]] and medullary thyroid carcinoma.
* In 1966, Williams ''et al.'' described the combination of mucosal neuromas, [[pheochromocytoma]], and medullary thyroid carcinoma.
* In 1978, Cameron suggested that medullary thyroid cancer produces thyrocalcitonin from [[parafollicular cell]]s.
* In 1978, Cameron suggested that medullary thyroid cancer produces thyrocalcitonin from [[parafollicular cell]]s.



Revision as of 20:07, 30 November 2015

Medullary thyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Medullary thyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Medullary thyroid cancer historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Medullary thyroid cancer historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Medullary thyroid cancer historical perspective

CDC on Medullary thyroid cancer historical perspective

Medullary thyroid cancer historical perspective in the news

Blogs on Medullary thyroid cancer historical perspective

Directions to Hospitals Treating Medullary thyroid cancer

Risk calculators and risk factors for Medullary thyroid cancer historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Medullary thyroid cancer was first discovered by John Beach Hazard, an American pathologist, in 1959.[1]

Historical Perspective

  • In 1959, Hazard et al. described medullary (solid) thyroid carcinoma.[2]
  • In 1961, Sipple described a combination of a pheochromocytoma, medullary thyroid carcinoma, and parathyroid adenoma.
  • In 1966, Williams et al. described the combination of mucosal neuromas, pheochromocytoma, and medullary thyroid carcinoma.
  • In 1978, Cameron suggested that medullary thyroid cancer produces thyrocalcitonin from parafollicular cells.

Discovery

Medullary thyroid cancer was first discovered by John Beach Hazard, an American pathologist, in 1959 following a specimen he observed which had solid non-follicular structure with amyloid in the stroma.[1]

References

  1. 1.0 1.1 HAZARD JB, HAWK WA, CRILE G (1959). "Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity". J. Clin. Endocrinol. Metab. 19 (1): 152–61. doi:10.1210/jcem-19-1-152. PMID 13620740.
  2. Dionigi G, Bianchi V, Rovera F, et al. (2007). "Medullary thyroid carcinoma: surgical treatment advances". Expert Rev Anticancer Ther. 7 (6): 877–85. doi:10.1586/14737140.7.6.877. PMID 17555398.


Template:WikiDoc Sources